A Message from Our CEO
Thank you for your interest in IQuity. We recognize patients are looking for answers. We also know that diagnosing and treating patients with autoimmune disease can be challenging. As we developed our research program, we have established a firm commitment to translating bench innovations into clinical practice.
IQuity was founded by scientists leveraging technology developed at Vanderbilt University Medical Center over the last decade. With funding from the National Institutes of Health and private investment, we are now bringing this new technology to communities that are desperately seeking advancements in diagnosis and treatment.
Our commitment is to transparency. IQuity’s science, processes and analytic capabilities are an open book. Through our website, scientific poster presentations and published papers, we are eager to share with you what we do, how we do it and ways we believe we can be of value to the healthcare community.
— Chase Spurlock, Ph.D., CEO of IQuity
Did you know that genes express themselves in different ways? They do - and they tell a story of an individual’s health and proclivity toward disease.